Recent news about Part the Cloud and Alzheimer's treatments

Exciting new Part the Cloud updates

In the news

Part the Cloud wins Anthem Award

Part the Cloud was recognized at The Anthem Awards under its innovative Health Event category! With Part the Cloud we have created a movement unlike any other in the Alzheimer’s and dementia space and we are proud of the continued impact we are making to accelerate scientific progress in Alzheimer's research by funding the most promising early phase studies.

Read more about the award here.

Researchers in the News

Cars and scientists with Dr. Ross Paterson

Ross Paterson, Ph.D., University College London, United Kingdom, is one of many international Part of Cloud award recipients. His research focuses on younger-onset Alzheimer's disease, rapid progressive dementias, cerebrospinal fluid (CSF) biomarkers, and studies of proteins involved with dementias. Dr. Paterson’s latest study involves protein clearance and finding a treatment that would stop tau production. Tau is a protein that primarily helps support nerve cell structure and transport nutrients within brain cells.

Get to know Dr. Paterson more in his YouTube series, “Cars and scientists,” where he marries his love for classic cars with scientific curiosity. 

Their Alzheimer's Disease Didn't Worsen. Why? — Case reports find one healthy habit in common

In a paper published in Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association, sustained vigorous exercise might have slowed disease progression in two individuals with confirmed brain changes associated with Alzheimer's and presence of mild cognitive impairment.

"We know that mild to moderate exercise is associated with a lower risk of developing dementia, including Alzheimer's disease, but the effects of vigorous, regular exercise have been poorly studied," said Davangere P Devanand, MD, a 2020 Part the Cloud Grant Program awardee. "If this initial report leads to future prospective, controlled studies that confirm that vigorous, sustained exercise can slow disease progression, widespread adoption of this approach is likely with major public health implications," Devanand and colleagues suggested. "Delaying Alzheimer's disease progression by even a few years will lead to enormous health care and societal cost savings."

A different line of work in his research team, Dr. Devanand’s Part the Cloud-funded research investigates if an antiviral treatment can impact brain changes seen with Mild Cognitive Impairment (MCI) and Alzheimer’s.

Learn more.

International Day of Women and Girls in Science

Featured Blog: Two-time PTC Awardee Dr. Krista Lanctôt
February 11 marked the annual International Day of Women and Girls in Science. Part the Cloud focuses on research poised to make changes in care and treatment more quickly, allowing clinical trials to get off-the-ground. In our latest blog post, Dr. Krista Lanctôt, a two-time Part the Cloud awardee, shares her hopes around Alzheimer's research. Read more here.

April 19, 2023: Part the Cloud Luncheon


To fund Alzheimer's research with the highest probability of slowing, stopping or ultimately curing Alzheimer's disease.